Jeffrey B Kaplan

Title: Innovations of Jeffrey B Kaplan

Introduction

Jeffrey B Kaplan is a notable inventor based in Monsey, NY (US), recognized for his contributions to the field of biofilm inhibition. With a total of 8 patents to his name, Kaplan has made significant strides in developing compositions and methods aimed at combating biofilm formation.

Latest Patents

Kaplan's latest patents include a biofilm inhibiting composition that utilizes polysaccharide-containing extracts isolated from host cells. These extracts contain nucleotide sequences encoding genes pamA, pamB, and pamC, which are capable of inhibiting biofilm formation produced by gram-negative bacteria, gram-positive bacteria, and fungi. Additionally, he has developed soluble β-N-acetylglucosaminidase-based antibiofilm compositions. This invention provides compositions comprising an antibiofilm enzyme similar to the dspB gene (DispersinB®) and an antimicrobial agent for preventing the growth and proliferation of biofilm-embedded microorganisms in both acute and chronic wounds. The methods outlined in this patent also include the preparation of medical devices, particularly wound care devices, using these antimicrobial compositions.

Career Highlights

Throughout his career, Kaplan has worked with esteemed institutions such as the University of Medicine and Dentistry of New Jersey and Rutgers, the State University of New Jersey. His work has focused on innovative solutions to medical challenges, particularly in the area of biofilm-related infections.

Collaborations

Kaplan has collaborated with notable colleagues, including Srinivasa Madhyastha and Karen Lovetri, contributing to the advancement of research in his field.

Conclusion

Jeffrey B Kaplan's innovative work in biofilm inhibition showcases his dedication to improving medical treatments and devices. His patents reflect a commitment to addressing significant health challenges through scientific research and collaboration.